Graeme M Mackenzie, GP Whitehaven CA28 7RG
Send response to journal:
Re: The next debate?
|
If you screen for and treat low risk you have to know very well what
the iatrogenic sequelae are from that strategy. Thus you may have very
good evidence that screening for and treating low risk individuals is
worthwhile in terms of the disease end points but what is the cost? By
looking for and treating high risk you protect many more people for the
anxiety and complex attitudinal change that can accrue from screening and
treating low risk. Life is probably only worth living with some element of
denial that we are mortal, perhaps even more so with the demise of
religious belief. Screening by its nature takes that denial away and
perhaps reduces us to neurotic, fearful individuals adding our risks to a
score card for most of our life and reacting negatively to anything other
than a very low score.
Competing interests:
None declared |